2021
DOI: 10.1016/j.biochi.2021.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Glucose starvation greatly enhances antiproliferative and antiestrogenic potency of oligomycin A in MCF-7 breast cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 58 publications
0
5
0
Order By: Relevance
“…Although there are some recent reports on the effects of oligomycins on cell proliferation, ,, the underlying mechanisms on cell proliferation remain largely unknown. Since the cell cycle is an important biological process regulating cell proliferation, we analyzed the effect of oligomycins on cell cycle by flow cytometry.…”
Section: Results and Discussionmentioning
confidence: 99%
“…Although there are some recent reports on the effects of oligomycins on cell proliferation, ,, the underlying mechanisms on cell proliferation remain largely unknown. Since the cell cycle is an important biological process regulating cell proliferation, we analyzed the effect of oligomycins on cell cycle by flow cytometry.…”
Section: Results and Discussionmentioning
confidence: 99%
“…In fact, this temperature dependence of ERα conformational changes, always seen in the case of AP-1 transcriptions, may reflect a two-step mechanism: the first step corresponds to ERα intracellular trafficking, eventually reflected in weak ERE transcriptions, and the second is relevant to the association of this formatted receptor with the AP1 complex to active a TRE with TPA. A physiological/pathological thermodynamic regulation is logically related to energy production changes [60], represented by the temperature dependence of binding affinity. Hence, according to our data, AP-1/ERE antagonism would govern the development of breast cancers according to energy-regulating cycles in which the mitochondria are implicated [61].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, additional therapeutic approaches are required to improve the clinical outcomes of CDN1 and CDN3, and we screened 2 potential therapeutic drugs for CDN1, including brefeldin A and oligomycin A. Because of its apoptosis-inducing activity in cancer cells, brefeldin A may act as a sensitive drug for CDN1 isoforms[48], and oligomycin A can suppress tumors by inhibiting the proliferation of tumor cells [49]. No sensitive drugs were screened in CDN3, but CDN3 showed elevated lipid metabolism and glucose metabolism.…”
Section: Discussionmentioning
confidence: 99%